Panelists discuss how C3 glomerulopathy (C3G) is triggered by factors like infections or pregnancy that activate the alternative pathway in genetically predisposed individuals, presenting with diverse clinical manifestations that often overlap with other glomerular diseases, making diagnosis challenging without kidney biopsy.
This summary captures key points from a discussion between Jonathan Barratt, MBChB, PhD, FRCP,and other panelists regarding C3G.
Triggers and Pathogenesis
Patients with C3G have underlying genetic predisposition present from birth but disease manifests only after specific triggers
Common triggers mirror those of atypical hemolytic uremic syndrome:
Infections
Pregnancy
Episodes of kidney injury
The role of autoantibodies (“intrinsic factors”) that stabilize complement convertases:
May develop through molecular mimicry following microbial infections
These antibodies inadvertently bind to complement convertases, preventing proper regulation
Diagnostic Challenges
Clinical presentation is highly variable and can mimic other glomerular diseases:
Can present with nephritic or nephrotic patterns
May resemble minimal change disease
Can mimic IgA nephropathy
May present as rapidly progressive glomerulonephritis with acute kidney injury
Complement testing has limitations:
Low serum C3 may provide a clue but is not universal
Normal C3 and C4 levels do not rule out C3G
Kidney biopsy remains essential for definitive diagnosis
In pediatric patients, C3G often initially resembles postinfectious glomerulonephritis (PIGN)
Persistence of glomerulonephritis features beyond expected PIGN resolution time should raise suspicion
Some pediatric cases present with pure nephrotic syndrome without hypocomplementemia
C3G must be considered in the differential diagnosis for any glomerular disease presentation, regardless of complement levels, due to its highly variable presentation and overlap with other kidney disorders.